Gibraltar Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$719K Buy
622
+124
+25% +$146K 0.11% 92
2026
Q2
$597K Buy
498
+101
+25% +$103K 0.09% 96
2026
Q1
$365K Sell
397
-23
-5% -$23.3K 0.06% 102
2025
Q4
$451K Buy
+420
New +$402K 0.08% 94
2025
Q3
– Sell
-391
Closed -$305K – 115
2025
Q2
$305K Buy
391
+9
+2% +$6.99K 0.06% 95
2025
Q1
$316K Sell
382
-244
-39% -$203K 0.07% 88
2024
Q4
$483K Buy
626
+5
+0.8% +$4.14K 0.21% 36
2024
Q3
$550K Buy
+621
New +$558K 0.25% 34

Other funds holding LLY

Gibraltar Capital Management's LLY Position: Q3 2026 in Review

Gibraltar Capital Management increased its Eli Lilly (LLY) stake by 25% in Q3 2026, buying an estimated $146K and bringing the position to 622 shares worth $719K. The position accounts for 0.11% of the portfolio, ranked #92.

Gibraltar Capital Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Gibraltar Capital Management held 622 shares of Eli Lilly worth $719K as of Q3 2026.
  • Gibraltar Capital Management bought 124 Eli Lilly shares in Q3 2026, an estimated $146K.
  • Eli Lilly made up 0.11% of Gibraltar Capital Management's portfolio in Q3 2026, its #92 holding.
  • Gibraltar Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Gibraltar Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.